STOCK TITAN

Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Yield10 Bioscience (Nasdaq: YTEN) has announced its participation in the Benzinga Global Small Cap Conference on December 9, 2021. President and CEO Oliver Peoples, Ph.D. will present at 10:30 AM EST, followed by one-on-one meetings with registered investors. An archived replay of the presentation will be accessible via the conference website. Yield10 focuses on agricultural bioscience, utilizing its Trait Factory platform to develop superior Camelina varieties and high-value genetic traits for various crops.

Positive
  • None.
Negative
  • None.

WOBURN, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that management will participate at the Benzinga Global Small Cap Conference on December 9, 2021.

President and Chief Executive Officer Oliver Peoples, Ph.D. will deliver his presentation at 10:30 AM EST on Thursday, December 9, 2021. Dr. Peoples will also be available to participate in one-on-one meetings with investors who are registered to attend the conference. An archived replay of the presentation will be available via the conference website.

Investors can register for the conference here:
https://www.benzinga.com/events/small-cap/december-2021-global/

About Yield10 Bioscience

Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina for the production of feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.

For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.

Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR

Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR


FAQ

What will Yield10 Bioscience present at the Benzinga Global Small Cap Conference on December 9, 2021?

Yield10 Bioscience will present at the Benzinga Global Small Cap Conference at 10:30 AM EST.

Who is the CEO of Yield10 Bioscience?

The CEO of Yield10 Bioscience is Oliver Peoples, Ph.D.

Where can I register for the Benzinga Global Small Cap Conference?

Registration for the Benzinga Global Small Cap Conference can be done through its official website.

What is the focus of Yield10 Bioscience?

Yield10 Bioscience focuses on agricultural bioscience, specifically developing improved Camelina varieties and high-value genetic traits.

What is the stock symbol for Yield10 Bioscience?

The stock symbol for Yield10 Bioscience is YTEN.

YIELD10 BISCIENCE INC NEW

OTC:YTEN

YTEN Rankings

YTEN Latest News

YTEN Stock Data

1.52M
567.28k
17.55%
0.03%
0.39%
Agricultural Inputs
Basic Materials
Link
United States of America
WOBURN